Sonnet BioTherapeutics Holdings, Inc. (SONN)
NASDAQ: SONN · Real-Time Price · USD
1.150
-0.030 (-2.54%)
At close: Jun 13, 2025, 4:00 PM
1.140
-0.010 (-0.87%)
After-hours: Jun 13, 2025, 6:41 PM EDT
SONN Market Cap
SONN has a market cap or net worth of $3.64 million as of June 13, 2025. Its market cap has decreased by -29.11% in one year.
Market Cap
3.64M
Enterprise Value
1.67M
1-Year Change
-29.11%
Ranking
Category
Stock Price
$1.15
Market Cap Chart
Since April 2, 2020, SONN's market cap has decreased from $58.10M to $3.64M, a decrease of -93.73%. That is a compound annual growth rate of -41.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 13, 2025 | 3.64M | -17.08% |
| Dec 31, 2024 | 4.39M | -17.79% |
| Dec 29, 2023 | 5.34M | -41.46% |
| Dec 30, 2022 | 9.12M | -63.34% |
| Dec 31, 2021 | 24.89M | -35.01% |
| Dec 31, 2020 | 38.30M | -34.08% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 736.37B |
| Johnson & Johnson | 378.52B |
| Novo Nordisk | 357.59B |
| AbbVie | 338.64B |
| UnitedHealth Group | 285.27B |
| Abbott Laboratories | 237.40B |
| Novartis AG | 236.22B |
| AstraZeneca | 232.37B |